Directed differentiation of cholangiocytes from human pluripotent stem cells

Nature Biotechnology

Volumn 33, Issue 8, 2015, Pages 853-861

  Ogawa, Mina ^a,b   Ogawa, Shinichiro ^a   Bear, Christine E ^c   Ahmadi, Saumel ^c   Chin, Stephanie ^c   Li, Bin ^d   Grompe, Markus ^d   Keller, Gordon ^a,e,f   Kamath, Binita M ^g,h   Ghanekar, Anand ^a,b,f  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL SIGNALING;

CELLULAR EVENTS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATORS; DIRECTED DIFFERENTIATIONS; EPITHELIAL CELLS; EPITHELIAL FUNCTIONS; NOTCH SIGNALING; PLURIPOTENT STEM CELLS; THREE-DIMENSIONAL CULTURE;

STEM CELLS;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MESSENGER RNA; NOTCH RECEPTOR; RECEPTOR; SECRETIN; SECRETIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BILE DUCT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CHOLANGIOCYTE; COCULTURE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; EUKARYOTIC FLAGELLUM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VIVO STUDY; LIVER DEVELOPMENT; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN SECRETION; CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; STEM CELL RESEARCH;

BILE DUCTS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; PLURIPOTENT STEM CELLS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELL RESEARCH;

EID: 84938874118     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3294     Document Type: Article

References (44)

1. O'Hara, S.P., Tabibian, J.H., Splinter, P.L. & LaRusso, N.F. The dynamic biliary epithelia: molecules, pathways, and disease. J. Hepatol. 58, 575-582 (2013).
2. Kamath, B.M. et al. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience. Liver Transpl. 18, 940-948 (2012).
3. Si-Tayeb, K. et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51, 297-305 (2010).
4. Touboul, T. et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 51, 1754-1765 (2010).
5. Takayama, K. et al. Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1alpha transduction. J. Hepatol. 57, 628-636 (2012).
6. Ogawa, S. et al. Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 140, 3285-3296 (2013).
7. Dianat, N. et al. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology 60, 700-714 (2014).
8. Si-Tayeb, K., Lemaigre, F.P. & Duncan, S.A. Organogenesis and development of the liver. Dev. Cell 18, 175-189 (2010).
9. Zong, Y. et al. Notch signaling controls liver development by regulating biliary differentiation. Development 136, 1727-1739 (2009).
10. Hofmann, J.J. et al. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development 137, 4061-4072 (2010).
11. Kodama, Y., Hijikata, M., Kageyama, R., Shimotohno, K. & Chiba, T. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 127, 1775-1786 (2004).
12. Geisler, F. et al. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 48, 607-616 (2008).
13. Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16, 243-251 (1997).
14. McDaniell, R. et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79, 169-173 (2006).
15. Kamath, B.M. et al. NOTCH2 mutations in Alagille syndrome. J. Med. Genet. 49, 138-144 (2012).
16. Gouon-Evans, V. et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat. Biotechnol. 24, 1402-1411 (2006).
17. Zaret, K.S. & Grompe, M. Generation and regeneration of cells of the liver and pancreas. Science 322, 1490-1494 (2008).
18. Suzuki, A., Sekiya, S., Buscher, D., Izpisua Belmonte, J.C. & Taniguchi, H. Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression. Development 135, 1589-1595 (2008).
19. Lüdtke, T.H., Christoffels, V.M., Petry, M. & Kispert, A. Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation. Hepatology 49, 969-978 (2009).
20. Raynaud, P., Carpentier, R., Antoniou, A. & Lemaigre, F.P. Biliary differentiation and bile duct morphogenesis in development and disease. Int. J. Biochem. Cell Biol. 43, 245-256 (2011).
21. Schmitt, T.M. & Zuniga-Pflucker, J.C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17, 749-756 (2002).
22. Lehar, S.M., Dooley, J., Farr, A.G. & Bevan, M.J. Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 105, 1440-1447 (2005).
23. Fernández-Sánchez, V. et al. In vitro effects of stromal cells expressing different levels of Jagged-1 and Delta-1 on the growth of primitive and intermediate CD34(+) cell subsets from human cord blood. Blood Cells Mol. Dis. 47, 205-213 (2011).
24. Takayama, K. et al. CCAAT/enhancer binding protein-mediated regulation of TGFbeta receptor 2 expression determines the hepatoblast fate decision. Development 141, 91-100 (2014).
25. Dorrell, C. et al. Transcriptomes of the major human pancreatic cell types. Diabetologia 54, 2832-2844 (2011).
26. Irion, S. et al. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat. Biotechnol. 25, 1477-1482 (2007).
27. Dekkers, J.F. et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat. Med. 19, 939-945 (2013).
28. Molinski, S. et al. Functional rescue of F508del-CFTR using small molecule correctors. Front. Pharmacol. 3, 160 (2012).
29. Eckford, P.D., Li, C., Ramjeesingh, M. & Bear, C.E. Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner. J. Biol. Chem. 287, 36639-36649 (2012).
30. Okiyoneda, T. et al. Mechanism-based corrector combination restores DeltaF508-CFTR folding and function. Nat. Chem. Biol. 9, 444-454 (2013).
31. Tanimizu, N. & Miyajima, A. Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J. Cell Sci. 117, 3165-3174 (2004).
32. Tanimizu, N., Saito, H., Mostov, K. & Miyajima, A. Long-term culture of hepatic progenitors derived from mouse Dlk+ hepatoblasts. J. Cell Sci. 117, 6425-6434 (2004).
33. Clotman, F. et al. Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev. 19, 1849-1854 (2005).
34. Turner, R. et al. Human hepatic stem cell and maturational liver lineage biology. Hepatology 53, 1035-1045 (2011).
35. Cardinale, V. et al. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology 54, 2159-2172 (2011).
36. Leeuwen, L., Fitzgerald, D.A. & Gaskin, K.J. Liver disease in cystic fibrosis. Paediatr. Respir. Rev. 15, 69-74 (2014).
37. Van Goor, F. et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc. Natl. Acad. Sci. USA 108, 18843-18848 (2011).
38. Zhao, D. et al. Derivation and characterization of hepatic progenitor cells from human embryonic stem cells. PLoS ONE 4, e6468 (2009).
39. Yanagida, A., Ito, K., Chikada, H., Nakauchi, H. & Kamiya, A. An in vitro expansion system for generation of human iPS cell-derived hepatic progenitor-like cells exhibiting a bipotent differentiation potential. PLoS ONE 8, e67541 (2013).
40. Kennedy, M., D'Souza, S.L., Lynch-Kattman, M., Schwantz, S. & Keller, G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109, 2679-2687 (2007).
41. Nostro, M.C., Cheng, X., Keller, G.M. & Gadue, P. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2, 60-71 (2008).
42. Nostro, M.C. et al. Stage-specific signaling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 138, 861-871 (2011).
43. Wong, A.P. et al. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat. Biotechnol. 30, 876-882 (2012).
44. Hotta, A. et al. EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat. Protoc. 4, 1828-1844 (2009).